Prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The fondair study

被引：0

作者：

Ageno, Walter ^{[1
]}

Riva, Nicoletta ^{[2
]}

Noris, Patrizia ^{[3
]}

Di Nisio, Marcello ^{[4
]}

La Regina, Micaela ^{[5
]}

Arioli, Dimitriy ^{[6
]}

Ria, Luigi ^{[7
]}

Monzani, Valter ^{[8
]}

Cuppini, Stefano ^{[9
]}

Lupia, Enrico ^{[10
]}

Pierfranceschi, Matteo Giorgi

Dentali, Francesco ^{[2
]}

机构：

[1] Univ InsubriaClin & Expt Med, Varese, Italy

[2] Univ Insubria, Varese, Italy

[3] Policlin San Matteo, I-27100 Pavia, Italy

[4] Univ G dAnnunzio, Pescara, Italy

[5] Osped S Andrea, La Spezia, Italy

[6] Arcispedale S Maria Nuova, Reggio Emilia, Italy

[7] Osped Sacro Cuore di Gesu, Gallipoli, Italy

[8] IRCCS Osped Maggiore Policlin, Milan, Italy

[9] Osped Rovigo, Rovigo, Italy

[10] Osped San Giovanni Bellinzona, Turin, Italy

来源：

THROMBOSIS RESEARCH | 2012年 / 130卷

关键词：

D O I：

10.1016/j.thromres.2012.08.064

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

页码：S125 / S125

页数：1

共 50 条

[1] Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study
Ageno, W.
Riva, N.
Noris, P.
Di Nisio, M.
La Regina, M.
Arioli, D.
Ria, L.
Monzani, V.
Cuppini, S.
Lupia, E.
Pierfranceschi, M. G.
Dentali, F.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (11) : 2291 - 2297
[2] Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study (vol 10, pg 2291, 2012)
Ageno, W.
Riva, N.
Noris, P.
Di Nisio, M.
La Regina, M.
Arioli, D.
Ria, L.
Monzani, V
Cuppini, S.
Lupia, E.
Pier-Franceschi, Giorgi M.
Dentali, F.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (01) : 225 - 225
[3] Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era
MacDougall, Kira
Spyropoulos, Alex C.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 42 (02) : 308 - 315
[4] An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients
Samama M.M.
Kleber F.-X.
Thrombosis Journal, 4 (1)
[5] A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
Samama, MM
Cohen, AT
Darmon, JY
Desjardins, L
Eldor, A
Janbon, C
Leizorovicz, A
Nguyen, H
Olsson, CG
Turpie, AG
Weisslinger, N
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11): : 793 - 800
[6] Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients
Offord, R
Lloyd, AC
Anderson, P
Bearne, A
PHARMACY WORLD & SCIENCE, 2004, 26 (04): : 214 - 220
[7] Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients
Robin Offord
Adam C. Lloyd
Pippa Anderson
Andy Bearne
Pharmacy World and Science, 2004, 26 : 214 - 220
[8] Venous thromboembolism prevention in acutely ill nonsurgical patients
Brophy, DF
Dougherty, JA
Garrelts, JC
Parish, RC
Rivey, MP
Stumpf, JL
Taylor, CT
Mathis, AS
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1318 - 1324
[9] The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE): Venous thromboembolism prophylaxis practices in acutely ill medical patients
Tapson, VF
Decousus, H
Bergmann, JF
Chong, BH
Froehlich, JB
Kakkar, AK
Merli, GJ
Monreal, M
Nakamura, M
Pavanello, R
Pini, M
Piovella, F
Spyropoulos, AC
Turpie, AGG
Zotz, RB
FitzGerald, G
Anderson, FA
BLOOD, 2004, 104 (11) : 488A - 488A
[10] Venous thromboembolism in acutely ill hospitalized medical patients
Barba, Raquel
Zapatero, Antonio
Losa, Juan E.
Marco, Javier
Plaza, Susana
Canora, Jesus
Manuel Casas, Jose
THROMBOSIS RESEARCH, 2010, 126 (04) : 276 - 279

← 1 2 3 4 5 →